$IBIO 4 SEC Filings

Filed On	Filing
15 Oct 2026	Form 4: Stoner Elizabeth, Director Granted 38,000 Stock Option (right to buy)
15 Oct 2026	Form 4: Kropotova Alexandra, Director Granted 38,000 Stock Option (right to buy)
15 Oct 2026	Form 4: Arkowitz David, Director Granted 38,000 Stock Option (right to buy)
15 Oct 2026	Form 4: Clark William D, Director Granted 38,000 Stock Option (right to buy)
15 Oct 2026	Form 4: Parada Antonio Bernardino Guimaraes, Director Granted 38,000 Stock Option (right to buy)
15 Oct 2026	Form 4: Sender Gary, Director Granted 38,000 Stock Option (right to buy)
04 Aug 2026	Form 4: Carr Molly, Chief Medical Officer Granted 430,000 Stock Option (right to buy)
19 May 2026	Form 4: Stoner Elizabeth, Director Granted 60,000 Stock Option (right to buy)
27 Mar 2026	Form 4: Banjak Marc, Chief Legal Officer Bought 13,934 shares ($23.1K)
23 Mar 2026	Form 4: Duran Felipe, Chief Financial Officer Bought 24,835 shares ($50.1K)
23 Mar 2026	Form 4: Brenner Martin, Director Bought 12,336 shares ($24.9K)
30 Jan 2026	Form 4: Banjak Marc, Chief Legal Officer Granted 146,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Duran Felipe, Chief Financial Officer Granted 179,000 Stock Option (right to buy)
30 Jan 2026	Form 4: Brenner Martin, Director Granted 479,000 Stock Option (right to buy)
24 Nov 2025	Form 4: Schimmelpennink Evert B., Director Granted 13,500 Stock Option (right to buy)
24 Nov 2025	Form 4: Clark William D, Director Granted 13,500 Stock Option (right to buy)
24 Nov 2025	Form 4: Sender Gary, Director Granted 13,500 Stock Option (right to buy)
24 Nov 2025	Form 4: Kropotova Alexandra, Director Granted 13,500 Stock Option (right to buy)
24 Nov 2025	Form 4: Parada Antonio Bernardino Guimaraes, Director Granted 13,500 Stock Option (right to buy)
24 Nov 2025	Form 4: Arkowitz David, Director Granted 13,500 Stock Option (right to buy)

Comments